SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-23-069474
Filing Date
2023-06-08
Accepted
2023-06-08 17:24:54
Documents
5
Group Members
LEWIS & CLARK PLANT SCIENCES FUND I, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2318258d1_sc13d.htm SC 13D 154286
2 EXHIBIT 99.1 tm2318258d1_ex99-1.htm EX-99.1 511182
3 EXHIBIT 99.2 tm2318258d1_ex99-2.htm EX-99.2 334126
4 EXHIBIT 99.3 tm2318258d1_ex99-3.htm EX-99.3 568388
5 EXHIBIT 99.4 tm2318258d1_ex99-4.htm EX-99.4 6483
  Complete submission text file 0001104659-23-069474.txt   1576125
Mailing Address 120 S. CENTRAL AVENUE, SUITE 1000 ST. LOUIS MO 63105
Business Address 120 S. CENTRAL AVENUE, SUITE 1000 ST. LOUIS MO 63105 314-392-5264
Lewis & Clark Ventures I, LP (Filed by) CIK: 0001648358 (see all company filings)

IRS No.: 472680451 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 (617) 616-8188
GreenLight Biosciences Holdings, PBC (Subject) CIK: 0001822691 (see all company filings)

IRS No.: 851914700 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92011 | Film No.: 231003019
SIC: 2836 Biological Products, (No Diagnostic Substances)